Essentials - Cannabis use disorder: Prevalence and Consequences-Handout - - Essentials

Handout - - Essentials - Cannabis Use Disorder
Pdf Summary
This document is a presentation on cannabis use disorder, its prevalence, consequences, and treatment options. The speaker begins by discussing the disclosure policies and stating they have no financial conflicts of interest. They also mention that off-label use of medications and interventions may be discussed, and that discussions of brands, accessibility, and methods of cannabis use should not be seen as endorsements.<br /><br />The objectives of the presentation are to review criteria for cannabis use disorder and associated syndromes, explain the neurobiological effects of cannabinoids, discuss the epidemiology of cannabis use, evaluate and treat cannabis use disorder, identify psychiatric and medical complications, compare current treatment options, and discuss changing use patterns and public opinion.<br /><br />The presentation provides some basic information about cannabis, such as the fact that there are different species and hundreds of strains, and that cannabis derivatives with varying levels of THC and CBD are available. It also mentions that marijuana is the most commonly used illicit drug, and that rates of addiction vary.<br /><br />The speaker discusses medical marijuana, noting that there is no standard definition or indications and that illicit use has increased in states without medical marijuana laws. They also mention the approval of one prescription formulation of cannabidiol (CBD) for two pediatric seizure disorders.<br /><br />The document explains the interactions of cannabinoids with receptors in the body and differentiates between THC, which is psychoactive, and CBD, which is neuroprotective and antipsychotic. It also provides statistics on marijuana use among adolescents and the perceived risk of harm.<br /><br />The presentation discusses the various forms of cannabis and their potency, as well as the risks associated with synthetic cannabinoids. It also highlights the problems with legal cannabinoids, such as accessibility to minors, lack of research, impurities, and inaccurate labeling.<br /><br />The speaker focuses on three populations of concern: youth, mentally ill individuals, and pregnant women. They discuss the negative effects of cannabis use on the developing teenage brain, the increased risk of mental health issues, and the potential impact on pregnancy outcomes and child development.<br /><br />The document also explores the relationship between cannabis use and mental health, noting that marijuana use is common among individuals with psychiatric diagnoses and can worsen symptoms in some cases. The different psychiatric diagnoses related to cannabis, such as intoxication, use disorder, and withdrawal syndrome, are explained.<br /><br />The presentation covers screening, assessment, and diagnosis of cannabis use disorder, and discusses different pharmacological approaches for cannabis withdrawal and use disorder. It also includes information on psychotherapeutic approaches, harm reduction strategies, and motivational interviewing.<br /><br />The document concludes with a list of resources for further information on the topic.
Keywords
cannabis use disorder
prevalence
consequences
treatment options
disclosure policies
off-label use
neurobiological effects
epidemiology
psychiatric complications
medical complications